Aims to develop a cloud-based Global Data Sharing Platform to facilitate data and information sharing between industry and health authorities worldwide.
With a 45-year history of involvement in formulation dev and application, this design strategy lends significant ease and predictability to process scale-up.
Treatment could be used for people who test positive for COVID-19, avoiding hospitalization due to the progression of the disease, complementing the vaccine.